CRIS Current Research Information System

EVANGELISTI, CECILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.452
AS - Asia 2.077
EU - Europa 1.607
AF - Africa 120
SA - Sud America 101
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.427
VN - Vietnam 657
SG - Singapore 544
CN - Cina 474
GB - Regno Unito 340
IT - Italia 322
SE - Svezia 248
DE - Germania 203
HK - Hong Kong 121
IN - India 92
FR - Francia 81
RU - Federazione Russa 77
BR - Brasile 69
IE - Irlanda 61
ZA - Sudafrica 45
FI - Finlandia 43
NL - Olanda 38
CH - Svizzera 34
UA - Ucraina 32
KR - Corea 31
TG - Togo 30
EE - Estonia 29
JP - Giappone 29
CI - Costa d'Avorio 28
JO - Giordania 26
BG - Bulgaria 21
BE - Belgio 20
AR - Argentina 17
PL - Polonia 16
ID - Indonesia 14
CA - Canada 13
TH - Thailandia 12
IR - Iran 10
TR - Turchia 9
MX - Messico 8
PH - Filippine 8
AT - Austria 7
BD - Bangladesh 7
ES - Italia 7
IQ - Iraq 7
SA - Arabia Saudita 7
PK - Pakistan 6
CZ - Repubblica Ceca 5
SC - Seychelles 5
UZ - Uzbekistan 5
CO - Colombia 4
HR - Croazia 4
PT - Portogallo 4
DZ - Algeria 3
EC - Ecuador 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
TW - Taiwan 3
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
LB - Libano 2
LT - Lituania 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
VE - Venezuela 1
Totale 6.359
Salva come PNG Salva come JPEG
Città #
Singapore 387
Southend 291
Ashburn 263
Fairfield 216
Chandler 194
Houston 166
Bologna 142
Woodbridge 126
Ho Chi Minh City 115
Hong Kong 111
Dong Ket 110
Seattle 106
Hanoi 100
San Jose 95
Wilmington 95
Santa Clara 94
Ann Arbor 91
Cambridge 91
Princeton 64
Beijing 61
Dublin 61
Hefei 54
Dallas 49
Boardman 46
New York 46
Helsinki 40
Bern 32
Lauterbourg 30
Lomé 30
Westminster 30
Nanjing 29
Abidjan 28
Council Bluffs 27
Los Angeles 27
Padova 27
Amman 26
Haiphong 25
Seoul 25
Berlin 23
Redmond 22
Bremen 21
Sofia 21
Frankfurt am Main 20
Brussels 19
Da Nang 19
Tokyo 18
Turin 18
Falls Church 15
Johannesburg 15
Shenyang 15
Nuremberg 14
Saint Petersburg 14
Changsha 13
Jinan 13
Redondo Beach 13
Shanghai 13
Warsaw 12
Buffalo 11
Guangzhou 11
Milan 10
Jakarta 9
London 9
The Dalles 9
Tianjin 9
Rome 8
Atlanta 7
Bengaluru 7
Chicago 7
Dearborn 7
Florence 7
Munich 7
Nanchang 7
Orem 7
São Paulo 7
Hebei 6
Hải Dương 6
Norwalk 6
Pune 6
San Diego 6
Toronto 6
Vienna 6
Zhengzhou 6
Can Tho 5
Denver 5
Falkenstein 5
Hyderabad 5
Jacksonville 5
Jiaxing 5
Medford 5
Mexico City 5
Mumbai 5
Yubileyny 5
Amsterdam 4
Ankara 4
Bangkok 4
Biên Hòa 4
Chennai 4
Fuzhou 4
Hangzhou 4
Mülheim 4
Totale 4.137
Salva come PNG Salva come JPEG
Nome #
Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer 270
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 258
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 256
INPP4B overexpression and c-KIT downregulation in human achalasia. 255
Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways 254
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 221
Therapeutic targeting of CK2 in acute and chronic leukemias. 218
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 209
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 204
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 203
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 199
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. 191
Case report: Functional characterization of a novel CHD7 intronic variant in patients with CHARGE syndrome 188
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 188
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 186
Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice 182
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia 179
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 177
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 175
C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. 175
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 174
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 173
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 172
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 171
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 170
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 167
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 164
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 162
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 159
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 158
Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. 138
Experimental Cell Models for Investigating Neurodegenerative Diseases 133
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation. 131
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 98
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 83
Low-Level Mosaicism in Tuberous Sclerosis Complex (TSC): Diagnostic and Clinical Implications From Two Novel Cases and Literature Review 49
Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance 2
Totale 6.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 0 0 0 0 24 30 239
2021/2022789 85 18 43 56 75 48 11 44 23 112 155 119
2022/2023799 78 117 38 112 38 70 29 40 149 13 60 55
2023/2024271 26 30 16 30 25 81 8 12 8 8 16 11
2024/2025789 25 94 69 83 143 50 45 37 7 52 45 139
2025/20261.951 159 147 166 152 218 131 264 80 485 149 0 0
Totale 6.492